Tegafi Capsule

Product Description

Tegafi capsules are a specialized chemotherapy treatment designed to combat metastatic colorectal cancer, a condition marked by the uncontrolled proliferation of malignant cells in the colon or rectum. Each capsule contains a potent combination of tegafur (100 mg) and uracil (224 mg), working synergistically to enhance the effectiveness of cancer therapy. Tegafur is a prodrug that transforms into the active chemotherapy agent 5-fluorouracil in the body, while uracil helps to increase the concentration of the active drug, thereby improving its therapeutic impact. It is important to note that Tegafi is not suitable for children or adolescents, and patients should be closely monitored for potential side effects during treatment. As with any chemotherapy regimen, it is crucial to discuss potential interactions with other medications and underlying health conditions with a healthcare professional. If you or a loved one are facing a diagnosis of metastatic colorectal cancer, Tegafi may offer a valuable treatment option as part of a comprehensive cancer care plan. Always consult your physician for personalized advice and to determine if Tegafi is the right choice for your specific medical needs.